Regard to patient safety. what we re looking here is not an inadequate central looking here is not an inadequate central mechanism but what some of the systems have identified concerns, but they were not adequately followed through. this is adequately followed through. this is a common adequately followed through. this is a common theme in these cases of clinical a common theme in these cases of clinical safety. there. the first would clinical safety. there. the first would be clinical safety. there. the first would be ensuring there is a nonexecutive director sitting on or chairing nonexecutive director sitting on or chairing the principal clinical governance committee in a trust in concerns governance committee in a trust in concerns could become an you would not have concerns could become an you would not have a concerns could become an you would not have a situation where the chairman not have a situation where the chairman of the board could state the board chair
This is a common theme in these cases of clinical failure. there are wa s. cases of clinical failure. there are ways- do cases of clinical failure. there are ways- do you cases of clinical failure. there are ways. do you think cases of clinical failure. there are ways. do you think we - cases of clinical failure. there are ways. do you think we will - cases of clinical failure. there are l ways. do you think we will see. there are ways. the first to ensure there is a nonexecutive director sitting on or chairing the principal clinical governance committee and the trust to which concern should have come and that would mean you did not have a situation where the chairman of the board for instance could say the board was not cited. nonexecutive scrutiny of clinical practice would be stronger if a nonexecutive director had a clinical background. and also a regular external review by whichever agency, and there are many, that take place for each trust, if greater scrutiny were plac